Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines.

antigen carrier epitope display intracellular antigen delivery peptide epitope protein DNA interaction protein scaffold engineering protein scaffold vaccine recombinant vaccine

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 31 05 2022
accepted: 19 07 2022
entrez: 29 8 2022
pubmed: 30 8 2022
medline: 31 8 2022
Statut: epublish

Résumé

Polycationic resurfaced proteins hold great promise as cell-penetrating bioreagents but their use as carriers for the intracellular delivery of peptide immuno-epitopes has not thus far been explored. Here, we report on the construction and functional characterization of a positively supercharged derivative of

Identifiants

pubmed: 36032169
doi: 10.3389/fimmu.2022.958123
pmc: PMC9405434
doi:

Substances chimiques

Antigens 0
Cell-Penetrating Peptides 0
Epitopes, B-Lymphocyte 0
Peptides 0
Vaccines, Subunit 0
Thioredoxins 52500-60-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

958123

Informations de copyright

Copyright © 2022 Cavazzini, Spagnoli, Mariz, Reggiani, Maggi, Franceschi, Donofrio, Müller, Bolchi and Ottonello.

Déclaration de conflit d'intérêts

PSC PfTrx and +21 PfTrx-(HPV16-L2)3x as well as other thioredoxin derivatives are covered by patents US9303082B2 and US10736954B2, in which some of the authors of the present work (AB, GS, MM and SO) appear as co-inventors. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest

Références

J Immunol. 2000 Feb 1;164(3):1625-33
pubmed: 10640784
Adv Mater. 2020 May;32(20):e1905309
pubmed: 31943419
ACS Chem Biol. 2007 Mar 20;2(3):167-70
pubmed: 17319644
Mol Biosyst. 2012 Aug;8(8):2036-40
pubmed: 22692102
Vaccine. 2009 Mar 18;27(13):1949-56
pubmed: 19368776
Nat Biotechnol. 2015 Jan;33(1):73-80
pubmed: 25357182
ACS Chem Biol. 2010 Aug 20;5(8):747-52
pubmed: 20545362
Methods Mol Biol. 2015;1348:137-51
pubmed: 26424270
Chem Biol. 2011 Jul 29;18(7):833-8
pubmed: 21802004
NPJ Vaccines. 2019 Jan 23;4:4
pubmed: 30701093
Sci Rep. 2017 Aug 29;7(1):9630
pubmed: 28851900
Biochemistry. 2018 Jan 23;57(3):314-323
pubmed: 29210575
FEBS J. 2019 May;286(9):1752-1764
pubmed: 30675750
Curr Protoc Bioinformatics. 2016 Jun 20;54:5.6.1-5.6.37
pubmed: 27322406
Infect Immun. 2008 Aug;76(8):3817-23
pubmed: 18474650
Sci Rep. 2014 Apr 22;4:4729
pubmed: 24751665
J Virol. 2018 Jan 30;92(4):
pubmed: 29212932
Biochim Biophys Acta. 2010 Jan;1805(1):25-34
pubmed: 19782720
J Am Chem Soc. 2012 Jan 18;134(2):909-11
pubmed: 22214519
J Control Release. 2021 Dec 10;340:209-220
pubmed: 34740725
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Nature. 1996 Apr 11;380(6574):548-50
pubmed: 8606778
Nature. 2021 Aug;596(7873):583-589
pubmed: 34265844
Protein Sci. 2018 Jan;27(1):112-128
pubmed: 28836357
Protein Sci. 2021 Jan;30(1):70-82
pubmed: 32881101
Angew Chem Int Ed Engl. 2016 Jan 22;55(4):1531-4
pubmed: 26695342
Protein Sci. 2016 Jun;25(6):1129-37
pubmed: 26991318
Sci Rep. 2017 Dec 21;7(1):18000
pubmed: 29269879
Cell Mol Life Sci. 2006 Mar;63(5):627-35
pubmed: 16482397
ACS Sens. 2018 Aug 24;3(8):1562-1568
pubmed: 29896952
Cell Chem Biol. 2017 Aug 17;24(8):924-934
pubmed: 28781125
Immunol Lett. 2018 Feb;194:29-39
pubmed: 29273425
Biomaterials. 2017 Jul;132:48-58
pubmed: 28407494
Materials (Basel). 2019 Aug 22;12(17):
pubmed: 31443361
Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6111-6
pubmed: 19307578
Nucleic Acids Res. 2018 Jul 2;46(W1):W296-W303
pubmed: 29788355
Chem Biol. 2012 Jul 27;19(7):831-43
pubmed: 22840771
J Am Chem Soc. 2007 Aug 22;129(33):10110-2
pubmed: 17665911
PLoS Pathog. 2020 Sep 4;16(9):e1008827
pubmed: 32886721
Methods Mol Biol. 2003;205:267-80
pubmed: 12491893
Cell Mol Life Sci. 2018 Aug;75(16):2887-2896
pubmed: 29508006
Nat Protoc. 2007;2(8):1849-61
pubmed: 17703195
Protein Expr Purif. 2017 Jan;129:150-157
pubmed: 27133916
Bioconjug Chem. 2014 Sep 17;25(9):1602-8
pubmed: 25133522
Nat Chem. 2019 Mar;11(3):204-212
pubmed: 30643229
Cancer Prev Res (Phila). 2015 Oct;8(10):932-41
pubmed: 26170394
Virology. 2011 Jan 20;409(2):348-59
pubmed: 21074234
Biomaterials. 2013 Jun;34(17):4360-7
pubmed: 23478039
Methods Enzymol. 2012;503:293-319
pubmed: 22230574
Cell Chem Biol. 2016 May 19;23(5):543-553
pubmed: 27203375
Nature. 2011 Sep 25;478(7370):515-8
pubmed: 21947006
Curr Opin Biotechnol. 2018 Aug;52:25-31
pubmed: 29486392

Auteurs

Davide Cavazzini (D)

Department of Chemistry, Life Sciences & Environmental Sustainability, University of Parma, Parma, Italy.

Gloria Spagnoli (G)

Department of Chemistry, Life Sciences & Environmental Sustainability, University of Parma, Parma, Italy.

Filipe Colaco Mariz (FC)

German Cancer Research Center (DKFZ), Tumorvirus-specific Vaccination Strategies (F035), Heidelberg, Germany.

Filippo Reggiani (F)

Department of Chemistry, Life Sciences & Environmental Sustainability, University of Parma, Parma, Italy.

Stefano Maggi (S)

Department of Chemistry, Life Sciences & Environmental Sustainability, University of Parma, Parma, Italy.

Valentina Franceschi (V)

Department of Veterinary Science, University of Parma, Parma, Italy.

Gaetano Donofrio (G)

Department of Veterinary Science, University of Parma, Parma, Italy.
Interdepartmental Center Biopharmanet-Tec, University of Parma, Parma, Italy.

Martin Müller (M)

German Cancer Research Center (DKFZ), Tumorvirus-specific Vaccination Strategies (F035), Heidelberg, Germany.

Angelo Bolchi (A)

Department of Chemistry, Life Sciences & Environmental Sustainability, University of Parma, Parma, Italy.
Interdepartmental Center Biopharmanet-Tec, University of Parma, Parma, Italy.

Simone Ottonello (S)

Department of Chemistry, Life Sciences & Environmental Sustainability, University of Parma, Parma, Italy.
Interdepartmental Center Biopharmanet-Tec, University of Parma, Parma, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH